SYSCHEM (INDIA)
|
The Current P/E Ratio of SYSCHEM (INDIA) is -638.55.
Share Price | ₹38.9 | Apr 11,2025 |
Market Cap | ₹169.2 Cr | |
Earnings-TTM | ₹-0.3 Cr | TTM-Standalone Results |
Price/Earnings | -638.55x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SYSCHEM (INDIA)
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹169.2 Cr] as on Apr 11,2025
(/) Earnings [ ₹-0.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -638.55x ]
Thus, for SYSCHEM (INDIA) , the investors are currently willing to pay -638.55 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SYSCHEM (INDIA) !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SYSCHEM (INDIA) over the last five years.
Historical PE (Price/Earnings) ratio chart of SYSCHEM (INDIA)
PE Ratio Performance Analysis for SYSCHEM (INDIA)
- SYSCHEM (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 23.56x.
- SYSCHEM (INDIA) 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SYSCHEM (INDIA) 's p/e ratio peaked in Mar2024 at 86.73x.
- SYSCHEM (INDIA) 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does SYSCHEM (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SYSCHEM (INDIA) | -0.27 | -638.55 | 169.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.25 | 404,900.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 71.83 | 148,474.0 |
CIPLA LTD | 5,000.43 | 23.63 | 118,166.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.85 | 105,849.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.05 | 92,553.6 |
MANKIND PHARMA LTD | 2,050.73 | 47.30 | 97,009.6 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.03 | 87,366.3 |
LUPIN LTD | 2,892.10 | 31.08 | 89,899.9 |
AUROBINDO PHARMA LTD | 3,500.25 | 17.96 | 62,874.7 |
ABBOTT INDIA LTD | 1,334.46 | 47.10 | 62,852.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SYSCHEM (INDIA) 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -638.55x |
Max industry PE | 71.83x |
Median industry PE | 31.08x |
Average industry PE | -24.68x |
You may also like the below Video Courses